ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,355Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 1171

$544K Total Retail Price of All Prescriptions

Rank: 187 out of 1171

738 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 738 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 738 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 6,766 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 952 440 S3 1 8
LISINOPRIL 453 319 2 3
OMEPRAZOLE 425 249 3 5
METOPROLOL TARTRATE 361 237 4 11
SIMVASTATIN 352 243 5 1
PRAVASTATIN SODIUM 300 186 6 13
METFORMIN HCL 293 179 7 7
HYDROCHLOROTHIAZIDE 282 223 8 9
FUROSEMIDE 281 163 9 6
LEVOTHYROXINE SODIUM 274 198 10 4
GABAPENTIN 207 95 11 16
AMLODIPINE BESYLATE 178 123 12 2
RANITIDINE HCL 174 88 13 38
PROAIR HFA 153 88 14 49
NEXIUM 142 52 15 25
TRAMADOL HCL 135 50 16 18
ZOLPIDEM TARTRATE 132 72 17 21
CYCLOBENZAPRINE HCL 129 56 R 18 67
GLIMEPIRIDE 122 80 19 34
ATORVASTATIN CALCIUM 112 89 20 10
WARFARIN SODIUM 110 98 21 12
IBUPROFEN 107 28 22 80
TRAZODONE HCL 105 72 23 37
ALLOPURINOL 99 76 24 31
LOSARTAN POTASSIUM 97 93 25 14
SPIRONOLACTONE 96 72 26 53
METOPROLOL SUCCINATE 95 93 27 17
ROPINIROLE HCL 85 66 28 119
CIPROFLOXACIN HCL 84 59 29 61
GEMFIBROZIL 84 36 29 117
ESCITALOPRAM OXALATE 79 44 31 69
LOVASTATIN 77 39 32 36
SERTRALINE HCL 76 31 33 23
CLONIDINE HCL 68 32 34 45
PANTOPRAZOLE SODIUM 63 53 35 29
SPIRIVA 62 39 36 57
NAPROXEN 61 25 37 95
INSULIN SYRINGE 59 25 38 71
PROMETHAZINE HCL 58 12 R 39 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 18 39 26
TAMSULOSIN HCL 57 53 41 28
POTASSIUM CHLORIDE 57 35 41 19
ENALAPRIL MALEATE 57 47 41 73
DONEPEZIL HCL 56 50 44 24
ATENOLOL 56 48 44 15
CLOPIDOGREL 54 38 46 35
SINGULAIR 54 15 46 78
ZETIA 53 35 48 63
FLUOXETINE HCL 52 33 49 76
ISOSORBIDE MONONITRATE ER 52 39 49 44
KLOR-CON M20 51 31 51 41
PLAVIX 50 38 52 55
CARVEDILOL 50 33 52 20
PAROXETINE HCL 50 17 52 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 6, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.